CSLLY
Price
$68.35
Change
-$0.40 (-0.58%)
Updated
Sep 5 closing price
Capitalization
66.31B
CVALF
Price
$1.66
Change
-$0.04 (-2.35%)
Updated
Sep 4 closing price
Capitalization
45.32M
Interact to see
Advertisement

CSLLY vs CVALF

Header iconCSLLY vs CVALF Comparison
Open Charts CSLLY vs CVALFBanner chart's image
CSL
Price$68.35
Change-$0.40 (-0.58%)
Volume$136.01K
Capitalization66.31B
Covalon Technologies
Price$1.66
Change-$0.04 (-2.35%)
Volume$201
Capitalization45.32M
CSLLY vs CVALF Comparison Chart in %
Loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSLLY vs. CVALF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a StrongBuy and CVALF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CSLLY: $68.35 vs. CVALF: $1.66)
Brand notoriety: CSLLY and CVALF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 161% vs. CVALF: 2%
Market capitalization -- CSLLY: $66.31B vs. CVALF: $45.32M
CSLLY [@Biotechnology] is valued at $66.31B. CVALF’s [@Biotechnology] market capitalization is $45.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileCVALF’s FA Score has 0 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • CVALF’s FA Score: 0 green, 5 red.
According to our system of comparison, CSLLY is a better buy in the long-term than CVALF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 4 TA indicator(s) are bullish while CVALF’s TA Score has 2 bullish TA indicator(s).

  • CSLLY’s TA Score: 4 bullish, 6 bearish.
  • CVALF’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than CVALF.

Price Growth

CSLLY (@Biotechnology) experienced а -1.41% price change this week, while CVALF (@Biotechnology) price change was -3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($66.3B) has a higher market cap than CVALF($45.3M). CVALF has higher P/E ratio than CSLLY: CVALF (25.44) vs CSLLY (22.16). CSLLY YTD gains are higher at: -21.295 vs. CVALF (-25.893). CSLLY has more cash in the bank: 1.52B vs. CVALF (18M). CVALF has less debt than CSLLY: CVALF (609K) vs CSLLY (12B).
CSLLYCVALFCSLLY / CVALF
Capitalization66.3B45.3M146,358%
EBITDAN/A4.73M-
Gain YTD-21.295-25.89382%
P/E Ratio22.1625.4487%
RevenueN/A33.8M-
Total Cash1.52B18M8,467%
Total Debt12B609K1,970,443%
FUNDAMENTALS RATINGS
CSLLY vs CVALF: Fundamental Ratings
CSLLY
CVALF
OUTLOOK RATING
1..100
6360
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
10071
SMR RATING
1..100
5655
PRICE GROWTH RATING
1..100
8777
P/E GROWTH RATING
1..100
9169
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSLLY's Valuation (2) in the null industry is somewhat better than the same rating for CVALF (63). This means that CSLLY’s stock grew somewhat faster than CVALF’s over the last 12 months.

CVALF's Profit vs Risk Rating (71) in the null industry is in the same range as CSLLY (100). This means that CVALF’s stock grew similarly to CSLLY’s over the last 12 months.

CVALF's SMR Rating (55) in the null industry is in the same range as CSLLY (56). This means that CVALF’s stock grew similarly to CSLLY’s over the last 12 months.

CVALF's Price Growth Rating (77) in the null industry is in the same range as CSLLY (87). This means that CVALF’s stock grew similarly to CSLLY’s over the last 12 months.

CVALF's P/E Growth Rating (69) in the null industry is in the same range as CSLLY (91). This means that CVALF’s stock grew similarly to CSLLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYCVALF
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 11 days ago
65%
Declines
ODDS (%)
Bearish Trend 12 days ago
65%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRG3.740.07
+1.91%
Seritage Growth Properties
TAK15.400.11
+0.72%
Takeda Pharmaceutical Company Limited
PECO36.150.12
+0.33%
Phillips Edison & Company
WRLD173.01-2.75
-1.56%
World Acceptance Corp
DRIO9.60-0.62
-6.07%
DarioHealth Corp

CSLLY and

Correlation & Price change

A.I.dvisor tells us that CSLLY and ADAP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSLLY and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
-0.58%
ADAP - CSLLY
32%
Poorly correlated
-19.61%
MLYS - CSLLY
32%
Poorly correlated
+5.07%
CDXS - CSLLY
31%
Poorly correlated
N/A
SEER - CSLLY
30%
Poorly correlated
+4.48%
ADPT - CSLLY
30%
Poorly correlated
-1.31%
More

CVALF and

Correlation & Price change

A.I.dvisor tells us that CVALF and ARGNF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVALF and ARGNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVALF
1D Price
Change %
CVALF100%
N/A
ARGNF - CVALF
22%
Poorly correlated
N/A
CYDY - CVALF
10%
Poorly correlated
-1.11%
GNMSF - CVALF
9%
Poorly correlated
+5.78%
CYYNF - CVALF
6%
Poorly correlated
N/A
CSLLY - CVALF
2%
Poorly correlated
-0.58%
More